Literature DB >> 32148086

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.

Mina K Chung, Lee L Eckhardt, Lin Y Chen, Haitham M Ahmed, Rakesh Gopinathannair, José A Joglar, Peter A Noseworthy, Quinn R Pack, Prashanthan Sanders, Kevin M Trulock.   

Abstract

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is associated with substantial morbidity, mortality, and healthcare use. Great strides have been made in stroke prevention and rhythm control strategies, yet reducing the incidence of AF has been slowed by the increasing incidence and prevalence of AF risk factors, including obesity, physical inactivity, sleep apnea, diabetes mellitus, hypertension, and other modifiable lifestyle-related factors. Fortunately, many of these AF drivers are potentially reversible, and emerging evidence supports that addressing these modifiable risks may be effective for primary and secondary AF prevention. A structured, protocol-driven multidisciplinary approach to integrate lifestyle and risk factor management as an integral part of AF management may help in the prevention and treatment of AF. However, this aspect of AF management is currently underrecognized, underused, and understudied. The purpose of this American Heart Association scientific statement is to review the association of modifiable risk factors with AF and the effects of risk factor intervention. Implementation strategies, care pathways, and educational links for achieving impactful weight reduction, increased physical activity, and risk factor modification are included. Implications for clinical practice, gaps in knowledge, and future directions for the research community are highlighted.

Entities:  

Keywords:  AHA Scientific Statements; atrial fibrillation; exercise; lifestyle; obesity; risk factors; weight loss

Mesh:

Year:  2020        PMID: 32148086     DOI: 10.1161/CIR.0000000000000748

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  50 in total

1.  Lifestyle modification for the management of atrial fibrillation.

Authors:  Yehia Fanous; Paul Dorian
Journal:  CMAJ       Date:  2020-11-16       Impact factor: 8.262

2.  2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society.

Authors:  Niraj Varma; Iwona Cygankiewicz; Mintu P Turakhia; Hein Heidbuchel; Yu-Feng Hu; Lin Yee Chen; Jean-Philippe Couderc; Edmond M Cronin; Jerry D Estep; Lars Grieten; Deirdre A Lane; Reena Mehra; Alex Page; Rod Passman; Jonathan P Piccini; Ewa Piotrowicz; Ryszard Piotrowicz; Pyotr G Platonov; Antonio Luiz Ribeiro; Robert E Rich; Andrea M Russo; David Slotwiner; Jonathan S Steinberg; Emma Svennberg
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-02-12

3.  Alcohol abstinence reduces A-fib burden in drinkers.

Authors:  Derrick J Thiel; Robert C Marshall; Tyler S Rogers
Journal:  J Fam Pract       Date:  2022-03       Impact factor: 0.493

4.  Change in Left Atrioventricular Coupling Index to Predict Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Théo Pezel; Bharath Ambale-Venkatesh; Thiago Quinaglia; Susan R Heckbert; Yoko Kato; Henrique Doria de Vasconcellos; Colin O Wu; Wendy S Post; Patrick Henry; David A Bluemke; João A C Lima
Journal:  Radiology       Date:  2022-02-22       Impact factor: 11.105

5.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.

Authors:  Yogesh N V Reddy; Masaru Obokata; Frederik H Verbrugge; Grace Lin; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-09-01       Impact factor: 24.094

6.  Paracrine Signals Modulate Atrial Epicardial Progenitor Cells and Development of Subepicardial Adiposity and Fibrosis Implications for Atrial Fibrillation.

Authors:  David R Van Wagoner
Journal:  Circ Res       Date:  2020-05-07       Impact factor: 17.367

Review 7.  Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Authors:  Stanley Nattel; Philip T Sager; Jörg Hüser; Jordi Heijman; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

8.  NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias.

Authors:  Larry Scott; Anke C Fender; Arnela Saljic; Luge Li; Xiaohui Chen; Xiaolei Wang; Dominik Linz; Jilu Lang; Mathias Hohl; Darragh Twomey; Thuy T Pham; Rodrigo Diaz-Lankenau; Mihail G Chelu; Markus Kamler; Mark L Entman; George E Taffet; Prashanthan Sanders; Dobromir Dobrev; Na Li
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

9.  Atrial Fibrillation (Part 1): Pathophysiology, Risk Factors, and Therapeutic Basis.

Authors:  Fatima Dumas Cintra; Marcio Jansen de Oliveira Figueiredo
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

10.  Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study.

Authors:  Hyo-Jeong Ahn; So-Ryoung Lee; Eue-Keun Choi; Kyung-Do Han; Jin-Hyung Jung; Jae-Hyun Lim; Jun-Pil Yun; Soonil Kwon; Seil Oh; Gregory Y H Lip
Journal:  PLoS Med       Date:  2021-06-08       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.